CF Foundation Collaboration with GeneGo Yields New Technology To Advance Drug Discovery

March 26, 2008

GeneGo, Inc., the leading systems biology tools company, announced today the release of MetaMiner Cystic Fibrosis, a first of its kind software and database platform designed to help advance drug discovery for CF. This novel, disease-specific tool will provide the CF research community with state-of-the art methods for integrating and analyzing cystic fibrosis data.

“MetaMiner Cystic Fibrosis is an important new tool for the cystic fibrosis research community,” said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation. “It will allow the integration of important new results with existing literature and speed up the rate of insights that can lead to new therapeutic interventions.” 
 
Read the full press release.